The same group showed that TLR9 deficiency attenuates CDAA diet-induced steatohepatitis and fibrosis, suggesting a critical role of TLR9 in NASH [44]. This evidence concerns the gene TLR9 and metabolic dysfunction-associated steatohepatitis.